Diansong Zhou
The University of Sydney(AU)Capital Medical University(CN)AstraZeneca (South Korea)(KR)Chinese Institute for Brain Research(CN)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Hepatocellular Carcinoma Treatment and Prognosis, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → In Vitro Evaluation of Potential Drug-Drug Interactions with Ticagrelor: Cytochrome P450 Reaction Phenotyping, Inhibition, Induction, and Differential Kinetics(2010)136 cited
- → Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups(2018)99 cited
- → Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children(2016)84 cited
- → COMPARISON OF METHODS FOR THE PREDICTION OF THE METABOLIC SITES FOR CYP3A4-MEDIATED METABOLIC REACTIONS(2006)75 cited
- → Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children(2017)75 cited
- → Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents